| Name | Title | Contact Details |
|---|
StarResource, LLC is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cmt Medical Technologies is a Valley Stream, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
OncoHealth is a leading digital health company dedicated to helping health plans, employers, providers, patients and life science researchers navigate the physical, mental and financial complexities of cancer through technology enabled services and real-world data analytics. Supporting more than 7 million people in the US and Puerto Rico, OncoHealth offers digital solutions for treatment review, real-world evidence, and virtual care across all cancer types.
YO1 Center is a destination well-being place which enhances health, agility and longevity and brings your state of mind to bliss and happiness. Built at the erstwhile Kutsher`s Resort in lush green surroundings that have two large lakes, it gives guests the opportunity to naturally revitalize their mind and body by employing the Eastern practices brought all the way from India, namely Naturopathy (or Nature Cure), Ayurveda, Yoga and Meditation, Physical Therapy, Acupuncture, Diet and Nutrition. YO1 (or Yauvan) in Sanskrit means Youth. It is the golden period in every human being`s life between teenage and adulthood. It highlights the yogic behavior of every individual in all walks of life. YO1 represents the manifestation of Yoga to fulfill the human quest of attaining eternal youth, through a complete rejuvenation of mind, body and soul. YO1 is about You+1, the literal Sanskrit meaning of Yoga being the `divine union`.
scPharmaceuticals, based in Lexington, MA, is a privately held biopharmaceutical company developing a portfolio of transformative pharmaceutical products for subcutaneous delivery. Based on widely used generic drugs that currently require intravenous or intramuscular injections, our innovative products will be administered subcutaneously via a proprietary patch pump. This avoids material risks and costs associated with the current delivery options. Our lead products are the first subcutaneous formulations of furosemide (the most widely used parenteral diuretic in treating heart failure) and ceftriaxone (the most widely used parenteral antibiotic outside the hospital setting). Our novel furosemide formulation enables convenient anytime anywhere use, for example in an outpatient setting instead of the emergency room or other in-patient settings. For ceftriaxone and other antibiotics, subcutaneous administration eliminates the need for PICCs (peripherally inserted central catheters), which are associated with serious complications, frequent adverse events and high medical cost. For further information on how we are transforming the administration of parenteral drugs.